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Following  the  commitments  of the  Tallinn  Charter,  Belgium  publishes  the  second  report
on  the  performance  of its health  system.  A  set of  74  measurable  indicators  is analysed,  and
results  are  interpreted  following  the  ﬁve  dimensions  of the  conceptual  framework:  acces-eywords:
ealth system
erformance indicators
enchmarking
sibility, quality  of care,  efﬁciency,  sustainability  and  equity.  All  domains  of care  are  covered
(preventive,  curative,  long-term  and end-of-life  care),  as  well  as  health  status  and  health
promotion.  For  all indicators,  national/regional  values  are  presented  with  their  evolution
over time.  Benchmarking  to results  of  other  EU-15  countries  is  also  systematic.  The  policy
recommendations  represent  the  most  important  output  of the  report.
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. Context
With the signing of the 2008 Tallinn Charter on health
ystems, the Member States of the European Region of
he World Health Organisation (WHO) formally committed
hemselves to transparency and the monitoring and eval-
ation of health system performance [1]. Two years after
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the signature of the Tallinn Charter, a ﬁrst Belgian feasi-
bility study on Health System Performance was published
[2]. A framework for evaluation was  deﬁned, and an initial
set of 40 indicators was developed. After the publication
of this feasibility study, the commissioners requested the
project to be continued, aiming at a systematic evaluation
of the Belgian health system. The current report, called the
Belgian Health System Performance Report 2012, presents
the result of this work [3].
2. The conceptual framework
Based on a systematic review of the literature and a
broad consultation of Belgian experts and stakeholders [1]
Open access under CC BY-NC-ND license.the Dutch and Canadian frameworks [4,5] were used as a
starting point to develop the Belgian performance assess-
ment framework. These frameworks were selected because
they are complementary and when combined cover the
r CC BY-NC-ND license.
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e the peFig. 1. Conceptual framework to evaluat
range of dimensions deemed as important by the con-
sulted experts and stakeholders for assessing the Belgian
health system performance. In addition, it was tailored to
the Belgian health system context (Fig. 1), by deﬁning the
scope of the framework as broad as possible (health system
instead of healthcare system) and by adding a new dimen-
sion directly relevant to policy makers (the sustainability
of the health system). In the resulting framework, three
interconnected tiers were determined, including health
status, non-medical determinants of health and a tier rep-
resenting health promotion and the health system (with
four domains of care: preventive care, curative care, long-
term care, and end-of-life care). The performance of the
health system is grouped into four main dimensions: qual-
ity, accessibility, efﬁciency, and sustainability. Quality of
care is further subdivided into ﬁve sub-dimensions (effec-
tiveness, appropriateness, safety, patient-centeredness,
continuity). Equity, the ﬁfth dimension, is a transversal
dimension which is presented across all tiers.
3. Strategic and operational objectives
In accordance with the Tallinn Charter and following
the recommendations for WHO  Europe [6,7], the process
of assessing the performance of a health system pursues
three strategic objectives:
(1) To inform the health authorities of the performance of
the health system and to be a support for policy plan-
ning.
(2) To provide a transparent and accountable view of the
Belgian health system performance, in accordance with
the commitment made in the Tallinn Charter.rformance of the Belgian health system.
(3) On the long term, to monitor the health system perfor-
mance over time.
Some operational objectives have also been deﬁned,
as the commissioners requested to enrich the initial set
of indicators with indicators in speciﬁc domains such as
health promotion, mental healthcare, primary care, long-
term care and end-of-life care, as those were insufﬁciently
covered in the feasibility study. Lastly, three dimen-
sions (i.e., continuity of care, patient centeredness and
equity) were considered to be insufﬁciently represented,
and new indicators had to be proposed to assess these
dimensions.
4. Implementation of health system performance
assessment
4.1. Main actors and key stakeholders
The assessment of the performance of the health sys-
tem was  initially launched in Belgium at the request of
the National Institute for Health and Disability Insurance
(NIHDI), which wanted to use international indicators
to monitor the performance of the system, to validate
international comparisons, and have a balanced view com-
plementing accessibility and cost information with other
indicators about quality, equity and sustainability. The cur-
rent report is the result of a collaborative effort of the
Belgian Health Care Knowledge Centre (KCE), the Belgian
Scientiﬁc Institute for Public Health and the NIHDI. In
addition, representatives from federal and regional admin-
istrations met  every four months to provide comments and
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eedback on draft versions of the report. They also discussed
otential political consequences of the report.
.2. Methods to select indicators, analysis and
resentation of results
Indexed as well as grey literature (i.e., reports from
ational or international organisations) was extensively
earched for new indicators in the domains/dimensions
entioned above. Selection of most relevant indicators
ccurred in collaboration with Belgian experts within each
omain.1 Maximal use was made of routinely collected,
ational available data (e.g., administrative databases or
ational registries) and of international databases (mainly
ECD Health Data [8] and Eurostat [9]). For all indica-
ors, national/regional values, with their evolution over
ime, were presented. Socio-economic disparities, as well
s benchmarking to results of EU-15 countries, were also
ystematically performed. All results were presented in
ynoptic tables with colour coding. Speciﬁc attention was
lso given to indicators for which there were no data (yet)
n Belgium. For some indicators, the current lack of data
ill be solved in the near future: evaluation of pathways
n ambulatory care, patient experience (available in next
ealth Interview Survey) or assessment of long-term care
y the Resident Assessment Instrument (RAI) [10]. For oth-
rs, only local studies or initiatives exist or data are made
vailable with a (too) long delay so that they do not reﬂect
ecent changes in the sector. These form the basis of rec-
mmendations to policy makers for new data collection.
. The 2012 set of indicators
The Belgian Health System Performance Report 2012
ontains 74 measurable indicators (see Tables 1–3). The
5 indicators related to the healthcare system are clas-
iﬁed by domain of care (preventive, curative, long-term
nd end-of-life care) and dimension (accessibility, qual-
ty of care, efﬁciency, sustainability and equity). Indicators
f health promotion, which involves responsibilities sit-
ated mainly outside of the healthcare system and even
eyond the health system, are presented separately. They
re classiﬁed using the Nutbeam model [11]. Four synthetic
ndicators of global health status are also presented. Finally,
wo new contextual indicators of equity are developed.
The number of indicators in each dimension and domain
eﬂects the availability of data: while 20 indicators related
o curative care could be measured, this was the case for
nly 6 and 5 indicators respectively for long-term and end-
f-life care. This highlights the scarcity of data in the latter
wo domains. Likewise, while for four sub-dimensions of
uality, at least 6 (up to 8) indicators were measured,
atient centeredness counts only three indicators, again
mphasising the difﬁculty to collect reliable data on this
imension.
1 The list of 38 external experts which were consulted to select the
ndicators is presented in the colophon of the report [3], and details on
he  literature searches (MeSH terms, databases searched, studies included
nd excluded) are presented in the appendices. 112 (2013) 133– 140 135
6. Main ﬁndings of the evaluation
6.1. Health status
The four indicators show a positive evolution over
time, but compared to the EU-15 average, Belgium ranks
lower for life expectancy, and lies in medium position
for health expectancy and infant mortality. Only self-
perceived health ranks higher than the EU-15 average.
6.2. Health promotion
Health promotion was  mostly approached by conven-
tional health and lifestyle indicators, complemented with
some indicators related to health policies, healthy settings,
and individual skills. Since the very limited availability
of suitable indicators and data, only a fragmented view
could be provided. Most health/lifestyle indicators show an
intermediate national rate, but important regional/social
disparities are observed. We  pinpoint the problem of
obesity/overweight that shows quite high and increasing
rates with severe disparities. The tobacco consumption
decreases, but with large social (see Table 3) and regional
disparities. The fruits and vegetables consumption is far
lower than the daily needs, but improves. The lack of
social support also shows important social and regional
disparities, and is particularly of concern in old people.
Belgium ranks at an intermediate level on the international
Tobacco Control Scale Policies (10th place in 31 European
countries).
6.3. Accessibility of health system
With regard to the ﬁnancial accessibility, despite a uni-
versal insurance coverage and the existence of social safety
nets, some concerns subsist (high level of out-of-pocket
expenses and increasing level of delayed contacts with
health services due to ﬁnancial reasons). The accessibility of
preventive measures shows quite discrepant results, with
a moderate and stable cancer screening coverage, a moder-
ate vaccination rate of inﬂuenza in the elderly, and a good
vaccination rate in children.
6.4. Quality of care
Quality was  studied through ﬁve sub-dimensions. Effec-
tiveness of care shows a mixed picture. Belgium scores
well on cancer 5-year survival rates. This good result
on survival is a possible explanation of the fact that the
ranking of Belgium for mortality in Europe (5th) is lower
than its ranking for incidence (1st) [12]. Poor results are
observed on mental health indicators, as Belgium has very
high suicide rates and an increasing level of involuntary
commitments in psychiatric hospitals. Appropriateness
of care reveals high and increasing rates of breast cancer
screening outside the target groups, moderate follow-up
of guidelines (antibiotics, diabetic patients) and increasing
rates of caesarean sections with large variability between
hospitals. Safety of care shows encouraging results, with
decreasing trends in hospital-acquired infections (MRSA)
and decreasing trends in exposure to medical radiation.
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Table 1
Indicator results to assess performance of Belgian Health System (global evaluation, national results compared to EU-15 countries, most recent data and trend over time).
Dimension/Indicator Globa l Belgium Most recent 
data
 Trend  over ti me
Indicators of Health Status
Life expe ctancy (yea rs) 80.0 201 0 increase
Health expe ctancy (at 25  years)
a
41.0 2008 increase
Self-pe rceived health (% in good  or  very good  hea lth) 76.8 200 8 increase
Infant mortality rate (number  of dea ths/100 0 live birt hs) 3.5 201 0 de crease
Indicator  of  Access ibility of  care
Workforce
Number  of  practising  physicians (per  1000  popu lation ) 2.9 201 0 stable
Number  of  practising  nurses (pe r 100 0 population ) 9.9 200 9 -
Fina ncial accessibili ty
Health insurance status of the popu lation ( %) 99.0 201 0 stable
Co-pa ymen ts and  out-of-pock et expend itures (% of total hea lth expend itures) 19.4 201 0 stable
Delayed  con tacts with health services because of fina ncial reasons (%) 14 200 8 increase
Coverage preventive measures
Breast cancer scree ning (% women aged 50-69 ) 60.1 201 0 stable
Cervix can cer  screening (% women aged 25-64) 61.8 201 0 stable
Vaccina tion  coverage  children  
- % Di phteria-Tetanos-Pertus sis-Haemoph ilus Influenzae B  (3rd dose-coverage) 97.9 200 9 increase
- %  Mea sles-Mumps-Ru bell a (f irst do se) 94.5 200 9 increase
Influen za vaccination (% of the 65+) 65.0 200 9 increase
Accessibili ty of lon g-term care
Numbe r of bed s in nu rsing  and reside ntial facilities (per  100 0 pop  ag ed 65+) 70.3 201 0 stable
Informal caregivers (% of  the 50+) 12.1 200 7 -
Accessibili ty of  end-of-li fe care
Timeli ness of pa lli ative care: dea ths within one  wee k after start  of pa lliative care service (%) (20 .0) 200 6 -
Indicato rs of Eff ecti veness of  care  (a subdime nsion of Quality)
5-yea rs relative survival rate 
- breast can cer (%) 88.0 2008  
-
- cervix can cer (%) 69.8 2008   -
- colon  cancer (%) 
b
M: 62.3 / F:  64 .6 2008   -
Hospital admissions for  asthma (per 100  000  pop  age d 15+) 48.4 2009   stable
Spe cific to mental hea lthcare
Suicide r ate (number  /100  000 pop ) 18.6 200 8 stable
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Table 1 (Continued )
Involuntary committals (% of all psychiatric hospitalizations) 8 2009 increase
Indicators of Appropriateness of Care (a subdimension of Quality)
Mammograms outside target group (%)
-Women aged  40-49  yea rs old 35.5 201 0 stable
-Women aged  71-79  yea rs old 20.8 201 0 increase
Antibiotics  (% amoxicil line compa red to amoxyclav) 44.9 200 8 stable
App rop riate follow up of adu lt  diab etic patien ts (r egu lar r etinal exams  and  blood tests) (%) 54 200 8 stable
Caesarean  sections (per  100 0 live births) 19 3 200 9 increase
Spe cific to mental hea lthcare
Presc ription  of (average dail y quan tity/1000 pop)
- Antidepressants 68.4 201 0 increase
Antipsychotics 10.5 2010 increase
Spe cific to end  of life care
Cancer patients receiving chemotherapy in the last 14 days of life (% of those dying at 
home/dying  in hospital)
(12%/ 23%) 2005
Indicators of Safety of care (a subdimension of Quality)
Medical radiation exposure of the Belgian population (MSv/capita) 2.2 2011 decrease
Incidence of hospital-acquired MRSA infections (/1000 discharges ) 1.5 2010 decrease
Incide nce of postoperative sep sis (/ 100 000 discha rges) 122 4 200 7 stable
Incidence of pressure ulcers in hospitals (%) 16.8 2007 increase
In-hospital mort ali ty after  hip fracture (%) 6.3 200 7 de crease
Patien ts prescribed  anticholi nergic an tidep ressan t drug  (% of the 65+ on antidep ressants) 14 201 0 stable
Indicators of Continuity of care (a subdimension of Quality)
Patien ts with a globa l medical record (%) 47 201 0 increase
Patien ts with can cer  discussed at the multidisciplina ry team mee ting  (%) 68.8 200 8 increase
GP  encounter  within the wee k after  hospital discha rge (% of the  65 +) 58.4 200 9 stable
Proportion  of contacts with the usual GP (%) (U sual Provide r of Care Inde x ≥  0.75) 71.4 201 0 stable
Spe cific to mental hea lthcare
Readmission within 30 days in the  same psychiatr ic hospital, diagno sis of schizoph renia (%) 20.2 200 9 increase
Readmission within 30 days in the  same psychiatr ic hospital, diagno sis of  bipolar  disorder  (%) 15.6 200 9 stable
Spe cific to end  of life care
Patien ts having  a con tact with their GP  during the last wee k of their  life (%) (72% ) 200 5 -
Indicato rs of P atient  Ce nteredness ( a subdimension of  Quality)
Satisfaction  with hea lthcare services (% good  or very good ) >90%  
c
2008 -
Pain always contr oll ed during ho spitalization (% of patients) (41 .0) 200 9 -
Patien ts dying  in their  usual place of residen ce (%) (45 .1) 200 7 increase
Indicato rs of Eff iciency of  the Health System
Global evaluation: very bad results, bad results; average results; good results; very good results; more data, more research, or targets are needed before an evaluation can be performed.
Colour  coding for international comparison: Belgium is situated in the group of countries EU-15 countries (grouped by quintiles) with: red (the worst results), orange (results worse than average), yellow (average
results),  light green (results better than average), dark green (the best results). International comparisons are based on the last year data are available in international health databases.
Results  between () in the column “Belgium” indicate that they are not representative for the whole country (results have been extracted from one study, and are not likely to be reproduced).
aInternational comparison is based on health expectancy at birth.
bResults for colorectal cancer in OECD Health Data for Belgium.
cThe satisfaction level is above 90% for contacts with GP, dentists, specialists and home care services. Only for hospitals the satisfaction level is a bit lower (87%).
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Table 2
Indicator of equity: progressivity indicators of the public ﬁnancing of the healthcare system.
Indicators of progressivity 2005 (ﬁnal
accounts) (%)
2006 (ﬁnal
accounts) (%)
2007 (ﬁnal
accounts) (%)
2008 (provisional
accounts) (%)
2009 (provisional
accounts) (%)
Ratio proportional receipts/total receipts 71.1 71.0 72.0 70.6 69.4
Ratio  progressive receipts/total receipts 18.9 19.0 18.0 17.3 17.2
Ratio  regressive receipts/total receipts 10.0 10.0 10.0 12.1 13.4
Total  100.0 100.0 100.0 100.0 100.0
Source: Vade mecum of social security, RIZIV – INAMI (KCE calculations).
Table 3
Summary of socioeconomic inequalities for selected indicators.
National
value
Value in lowest
social group
Value in highest
social group
Summary measure
(CII or PAF) (%)
General health status
Life expectancy at 25 in men (years)a 51.38 47.56 55.03 3.73
Life  expectancy at 25 in women (years)a 57.09 53.98 59.9 1.43
Healthy life years at 25 in men  (years)a 40.47 27.75 46.33 15.30
Healthy life years at 25 in women (years)a 40.42 28.92 47.1 16.56
%  of the population (aged 15+) that assess their health as good or very good 76.8% 57.4% 85.7% 11.6
Accessibility of care
Delayed contacts with health services because of ﬁnancial reasons (% of
households)
14.0% 27.0% 4.0% −71.4
Breast  cancer screening (% women  aged 50–69) 60.1% 48.6% 62.9% 4.7
Cervix cancer screening (% women aged 25–64) 61.8% 48.9% 64.2% 3.9
Appropriateness
%  of adult diabetes patients receiving appropriate care, in terms of regular
retinal exams and blood tests
54.0% 48.0% 58.0% 7.4
Health  promotion
% of the population (aged 15+) that reports to smoke daily 20.5% 22.0% 13.1% −36.1
%  of the population (aged 15+) reporting a poor social support 15.5% 24.4% 10.1% −34.8
%  of the adult population considered as being obese (BMI ≥ 30) 13.8% 19.2% 9.1% −34.1
%  of the adult population considered as being overweight or obese
(BMI ≥ 25)
46.9% 57.8% 40.0% −14.7
%  of the population reporting to eat at least 200 g vegetables and 2 fruits
per  day
26.0% 21.7% 29.4% 13.1
%  of the population reporting to practice at least 30 min  of physical activity
per day
38.1% 24.0% 42.8% 12.3
life and Summary measures = CII (concentration index of inequalities) relative for 
indicators.
a Results from 2001 (date of last national census in Belgium).
Continuity and coordination of care show mixed results.
On the one hand a good relational continuity with the
same physician and an increasing rate of multidisciplinary
consultation for cancer cases is shown. On the other hand
a low coverage of the global medical record2 and high
readmission rates in psychiatric hospitals are observed.
Finally, patient-centeredness could only be very partially
assessed, due to lack of data.
6.5. Efﬁciency of health system
Efﬁciency of the healthcare system shows average to
good results as assessed with an increase in prescrip-
tion of low-cost drugs, the use of one-day surgical care,
and decrease in length-of-stay for a normal delivery.
However, this has to be tempered by indicators showing
2 Patients can choose to open a global medical record. In this case, their
GP creates a record containing data on their health such as chronic ill-
ness, current treatments. Having a global medical record reduces fees for
GPs contacts, and is meant to increase coordination of care by giving a
coordination role to the GP.health expectancy, PAF (population attributable fraction) for all the other
inappropriate use of resources, such as increasing rates of
breast cancer screening outside the target groups.
6.6. Sustainability of health system
Sustainability of the Belgian health system shows some
worrying results regarding the replacement of the cur-
rent cohort of general practitioners. Moderate results are
observed for the system’s capacity to be innovative, as mea-
sured by the coverage of GPs using electronic medical ﬁles.
6.7. Equity and inequalities
Two  contextual indicators were analysed. First, the
public ﬁnancing of the healthcare system becomes less
progressive3 essentially for two reasons: the part of
the regressive receipts (indirect taxes) is increasing and
3 Progressive (regressive) ﬁnancing means that the proportion of
income collected to ﬁnance the health system increases (decreases) with
income. Proportional ﬁnancing means that this proportion is constant
with income.
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he part of the progressive receipts (direct taxes and
pecial contribution for social security) is decreasing
Table 2). Globally, these two evolutions make ﬁnancing
ess progressive. Second, the after-tax Gini coefﬁcient4 is
ncreasing (0.246 in 1990, 0.310 in 2010), indicating that
nequality is increasing in Belgium. The Gini coefﬁcient has
lso been shown to be related to the global health status
f a population [13].
In addition to social disparities in lifestyle and social
upport mentioned above, large disparities are observed in
ealth status, coverage of preventive measures, and some
ndicators of appropriateness of care (Table 3). Tackling
hese inequalities, which are not new [14] and not spe-
iﬁc to Belgium [15,16], will deﬁnitely represent one of the
ost difﬁcult challenges for policy makers. At the interna-
ional level, the importance of tackling health inequalities
as been stressed by the WHO  for a long time. Nowadays it
s also identiﬁed as a policy priority at the European level,
ith the DG Sanco 2d Health Programme [17,18].
. Recommendations to policy makers
The main strategic objective of a health system perfor-
ance assessment is to support policy makers by providing
hem information to help guiding new reforms. Hence, one
f the outputs of the report consists in policy recommen-
ations.
.1. Follow warning signals
Results show some warning signals which should alert
olicy makers: overweight and obesity, suicide, coverage
f cancer screening, follow-up of guidelines, medical radi-
tion, global medical record, readmission in psychiatric
ospitals, replacement of GPs, and large social disparities
or many indicators studied.
.2. More national targets are needed, as benchmarking
ith other European countries does not always provide
n answer
As few speciﬁc and quantiﬁed objectives are deﬁned
n Belgium, we compared our results to external targets
e.g., WHO-deﬁned), or benchmarked them to other EU-
5 countries to evaluate the performance. However, it
oes not solve the question of “are our results good or
ad?” Indeed, some results can be good when compared
o other countries, whilst they are not when confronted
ith the country objective. Moreover, international com-
arison of performance is still under debate [19], as the
any methodological pitfalls and contextual variations
ake meaningful comparisons difﬁcult.
4 The Gini coefﬁcient is a coefﬁcient for inequality of income in a pop-
lation. When there is perfect equality (everybody has the same income),
he  coefﬁcient is 0. When there is perfect inequality, the coefﬁcient is 1
one person has all the income). 112 (2013) 133– 140 139
7.3. Improve health information systems, especially
timeliness of data
Despite many recent efforts in supplying up to date data,
Belgium lies still behind in recent international bench-
marking reports. For instance, in the recent OECD report
Health at a Glance Europe 2012, the majority of quality of
care indicators for Belgium dates from 2007 [20]. While
some delays are inherent to the use of administrative data
or registries, this cannot justify such long delays. In such
cases, it will be very difﬁcult for policy makers to base
decisions on outdated information.
8. Conclusion
The 2012 performance report identiﬁes the strengths
and weaknesses of the Belgian health system as well as
the gaps in the available data. Performance is evaluated
through ﬁve dimensions, and across four domains of care
on the basis of 74 measured indicators. The monitoring
of the results of this report over time will be easy, as the
large majority of indicators is based on routinely collected
administrative data or on a periodically collected national
health survey. Since the publication of this report, working
groups from different health administrations were asked
by policy makers to monitor the actions and progresses
of each speciﬁc indicator which showed poor results. The
next report, scheduled for 2015, has already been commis-
sioned, and will include the evaluation of the progresses
made since the current situation.
In the context on the EU directive [21] on the applica-
tion of patients’ rights in cross-border care, this report not
solely lays down the basis of a future systematic perfor-
mance assessment but can be considered as an important
step towards Belgium’s responsibility to ensure safe, high
quality, accessible and efﬁcient healthcare for all patients.
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